Mortality in Barretts esophagus: Three decades of experience at a single center

Endoscopy

Volumn 44, Issue 10, 2012, Pages 892-898

  Caygill, C P J ^a   Royston, C ^b   Charlett, A ^c   Wall, C M ^a   Gatenby, P A C ^a   Ramus, J R ^a   Watson, A ^a   Winslet, M ^a   Bardhan, K D ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Rotherham NHS Foundation Trust   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CAUSE OF DEATH; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; ADENOCARCINOMA; BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS TUMOR; MIDDLE AGED; NATIONAL HEALTH SERVICE; POISSON DISTRIBUTION; SURVIVAL RATE; UNITED KINGDOM;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; BIOPSY; CAUSE OF DEATH; ENGLAND; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; STATE MEDICINE; SURVIVAL RATE;

EID: 84866425612     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1309842     Document Type: Article

References (50)

1. Parkin D. Global cancer statistics in the year 2000. Lancet Oncology: 2001; 2 533 543 (Pubitemid 33586866)
2. Available from: GLOBOCAN 2008 Fast Stats: International Agency for Research on Cancer. 2012; http://globocan.iarc.fr/factsheet.asp#BOTH Accessed: 27th April
3. Newnham A, Quinn M, Babb P et al. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999. Aliment Pharmacol Ther: 2003; 17 655 664 (Pubitemid 36418889)
4. Kocher H, Linklater K, Patel S et al. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg: 2001; 88 1249 1257 (Pubitemid 34015612)
5. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev: 1992; 1 265 269
6. Johnston BJ, Reed PI. Changing pattern of oesophageal cancer in a general hospital in the UK. Eur J Cancer Prev: 1991; 1 23 25
7. McKinney P, Sharp L, Macfarlane G et al. Oesophageal and gastric cancer in Scotland 1960-90. Br J Cancer: 1995; 71 411 415
8. SEER Cancer Statistics Review, 1975-2001. In: Ries L, Eisner M, Kosary C. et al., eds Bethesda, Maryland, USA National Cancer Institute: 2004
9. Daly J, Karnell L, Menck H. National Cancer Data Base Report on Esophageal Carcinoma. Cancer: 1996; 78 1820 1828 (Pubitemid 26330913)
10. Liabeuf A, Faivre J. Time trends in oesophageal cancer incidence in Cote dOr (France), 1976-93. Eur J Cancer Prev: 1997; 6 24 30 (Pubitemid 27239514)
11. Tuyns A. Oesophageal cancer in France and Switzerland: recent time trends. Eur J Cancer Prev: 1992; 1 275 278
12. Moller H. Incidence of cancer of the oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev: 1992; 1 159 164
13. Hansen S, Wiig J, Giercksky K et al. Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer: 1997; 71 340 344 (Pubitemid 27224293)
14. Bosch A, Frias Z, Caldwell W. Adenocarcinoma of the esophagus. Cancer: 1979; 43 1557 1561 (Pubitemid 9178540)
15. Puestow C, Gillesby W, Guynn V. Cancer of the esophagus. Arch Surg: 1955; 70 662 668
16. Turnbull A, Goodner J. Primary adenocarcinoma of the esophagus. Cancer: 1968; 22 915 918
17. Webb J, Busuttil A. Adenocarcinoma of the oesophagus and of the oesophagogastric junction. Br J Surg: 1978; 65 475 479 (Pubitemid 8372718)
18. Gelfand M, Finley R, Nelems B. Transhiatal esophagectomy for carcinoma of the esophagus and cardia. Arch Surg: 1992; 127 1164 1167
19. Putnam J, Suell D, McMurtrey M. Comparison of three techniques of oesophagectomy within a residency training program. Ann Thoracic Surg: 1994; 57 319 325 (Pubitemid 24101126)
20. Rahamim J, Cham C. Oesophagogastrectomy for carcinoma of the oesophagus and cardia. Br J Surg: 1993; 80 1305 1309 (Pubitemid 23313168)
21. Chalasani N, Wo J, Waring J. Racial differences in the histology, location and risk factors of esophageal cancer. J Clin Gastroenterol: 1998; 26 11 13 (Pubitemid 28076814)
22. Devesa S, Blot W, Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer: 1998; 83 2049 2053 (Pubitemid 28525384)
23. Blot W, Devesa S, Kneiler R et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA: 1991; 265 1287 1289
24. Lepage C, Rachet B, Jooste V et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol: 2008; 103 2694 2699
25. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barretts oesophagus: observational study. BMJ: 2000; 321 1252 1255
26. Mortality statistics for deaths registered in England and Wales in 1999. Available from: 2009; http://www.statistics.gov.uk/downloads/theme-health/ DR1999/DR-07-1999.pdf Accessed: 14 October
27. Bardhan KD, Royston C, Nayyar AK. Reflux rising! An essay on witnessing a disease in evolution. Dig Liv Dis: 2006; 38 163 168 (Pubitemid 44356161)
28. Cancer in South East England 1997. London, UK Thames Cancer Registry: 2000; 25
29. Watson A, Heading RC, Shepherd NA. Guidelines for the diagnosis and management of Barretts columnar-lined oesophagus. A report of the working party of the British Society of Gastroenterology 2005. Available from: 2009; http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/oesophageal/ Barretts-Oes.pdf Accessed: 14 October
30. Vakil N. Disease definition, clinical manifestations, epidemiology and natural history of GERD. Best Pract Res CL GA: 2010; 24 759 764
31. van Sandick JW, van Lanschot JJB, Kuiken BW et al. Impact of endoscopic biopsy surveillance of Barretts oesophagus on pathological stage and clinical outcome of Barretts carcinoma. Gut: 1998; 43 216 222 (Pubitemid 28348324)
32. Fitzgerald RC, Saeed IT, Khoo D et al. Rigorous surveillance protocol increases detection of curable cancers associated with Barretts esophagus. Dig Dis Sci: 2001; 46 1892 1898 (Pubitemid 32844155)
33. Accra E, Carey W. The cost of surveillance for adenocarcinoma complicating Barretts esophagus. Am J Gastroenterol: 1988; 83 291 294
34. British Society of Gastroenterology, Research, Clinical Trials Update, BOSS (Barretts Oesophagus Surveillance Study). Available from: 2011; http://www.bsg.org.uk/research/clinical-trials-updates/boss-barrett-s- oesophagus-surveillance-study.html Accessed: 5 October
35. Holdsworth CD, Atkinson M. Gastroenterology services: a regional review. Br Med J: 1984; 288 1245 1247 (Pubitemid 14079107)
36. Scott B, Atkinson M. Gastroenterology services: a regional review of changes over a five-year period (1981-86). Gut: 1989; 30 695 700 (Pubitemid 19147086)
37. Scott B. Gastroenterology in the Trent Region in 1992 and a review of changes since 1975. Gut: 1995; 36 468 472
38. Office for National Statistics. Census 2001. Rotherham. Available from: 2011; http://www.statistics.gov.uk/census2001/pyramids/pages//00cf.asp Accessed: 31 May
39. Shaheen NJ, Richter JE. Barretts esophagus. Lancet: 2009; 373 850 861
40. Ong C-A, Lao-Sirieiz P, Fitzgerald RC. Biomarkers in Barretts esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol: 2010; 16 5669 5681
41. Hvid-Jensen F, Pedersen L, MohrDrewes A et al. Incidence of adenocarcinoma among patients with Barretts esophagus. N Engl J Med: 2011; 365 1375 1383
42. Anderson LA, Murray LJ, Murphy SJ et al. Mortality in Barretts oesophagus: results from a population based study. Gut: 2003; 52 1081 1084 (Pubitemid 36877416)
43. Solaymani-Dodoran M, Logan RFA, West J et al. Mortality associated with Barretts esophagus and gastroesophageal reflux disease diagnosis - a population-based cohort study. Am J Gastroenterol: 2005; 100 2616 2621
44. Cook MB, Wild CP, Everett SM et al. Risk of mortality and cancer incidence in Barretts esophagus. Cancer Epidemiol Biomarkers Prev: 2007; 16 2090 2096 (Pubitemid 47621185)
45. Moayyedi P, Burch N, Akhtar-Danesh N et al. Mortality rates in patients with Barretts oesophagus. Aliment Pharmacol Ther: 2008; 27 316 320
46. Sontag SJ, Schnell TG, Chejfec G et al. Barretts oesophagus and colonic tumours. Lancet: 1985; 1 946 949
47. Howden CW, Hornung CA. A systematic review of the association between Barretts esophagus and colon neoplasms. Am J Gastroenterol: 1995; 10 1814 1819
48. Caygill CPG, Royston C, Charlett A et al. Barretts, blood groups and progression to esophageal cancer: Is nitric oxide the link? Eur J Gastroenterol Hepatol: 2011; 23 801 806
49. Gatenby PAC, Caygill CPJ, Ramus JR et al. Short segment columnar-lined oesophagus (CLO) - an underestimated cancer risk? A large cohort study of the relationship between Barretts CLO segment length and adenocarcinoma risk. Eur J Gastroenterol Hepatol: 2007; 19 969 975 (Pubitemid 350287403)
50. Allum WH, Blazeby JM, Griffin M et al. Guidelines for the management of oesophageal and gastric cancer. Gut: 2011; 60 1449 1472